REG-Regulated information – inside information: Fagron delivers strong 23.2% revenue growth in the third quarter to €281.3 million and confirms FY guidance range
Globe Newswire•08/10/2026•01:00 ET
3
Key Highlights
- ➤Q3 revenue €281.3 million, up 23.2% year over year
- ➤Organic growth 3.4% at CER, led by EMEA, Latin America and B&E
- ➤IV bag recall temporarily hurt North America–Pacific Compounding Services
- ➤Injeplast acquisition completed; all previously announced acquisitions closed
- ➤FY 2026 outlook confirmed at €1,125–€1,150 million revenue, 19.5%–20.0% adj. EBITDA margin
Expert Statements
Rafael Padilla, CEO of Fagron
“Our third quarter shows the strength of our diversified model.”
Rafael Padilla, CEO of Fagron
“In EMEA, growth was led by Compounding Services, driven by new customer wins and rising underlying demand, while in Latin America, performance was supported by a successful Consulfarma fair and our acquisitions in Brazil added further momentum.”
Rafael Padilla, CEO of Fagron
“In North America–Pacific, Brands & Essentials delivered another strong quarter, while Compounding Services was held back by the industry-wide IV bag recall.”
Rafael Padilla, CEO of Fagron
“Supply has now stabilized, and we expect volumes to recover progressively through the fourth quarter.”
Rafael Padilla, CEO of Fagron
“With Injeplast completed, all previously announced acquisitions are now closed and integrating well.”
Rafael Padilla, CEO of Fagron
“Our M&A pipeline remains strong, with a clear focus on disciplined, value-accretive opportunities to strengthen our global leadership.”
Rafael Padilla, CEO of Fagron
“For 2026, we expect revenue of €1,125 – €1,150 million with an adj. EBITDA margin of 19.5% – 20.0%.”
Rafael Padilla, CEO of Fagron
“We believe North America–Pacific has reached an inflection point.”
Rafael Padilla, CEO of Fagron
“As IV bag volumes recover, maintaining our quality leadership, our expansion projects come on stream and our acquisitions contribute fully, we are well positioned for a strong 2027.”
Rafael Padilla, CEO of Fagron
“Our mid-term objectives remain unchanged.”
Regulated information – inside information Nazareth-De Pinte (Belgium)/Rotterdam (The Netherlands), 8 October 2026 – 7:00 AM CET
Fagron delivers strong 23.2% revenue growth in the third quarter to €281.3 million and confirms FY guidance range
Get started
Create a free account to read the full story.